Crystal structure of a putative lysostaphin peptidase from Vibrio cholerae

Proteins: Structure, Function and Genetics

Volumn 72, Issue 3, 2008, Pages 1096-1103

  Ragumani, Sugadev ^a   Kumaran, Desigan ^a   Burley, Stephen K ^b   Swaminathan, Subramanyam ^a  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b SGX Pharmaceuticals Inc   (United States)

Author keywords

Glycyl glycine or glycyl alanine; Latent form; Lysostaphin peptidase; LytM

Indexed keywords

LYSOSTAPHIN; LYSOSTAPHIN PEPTIDASE;

ARTICLE; CRYSTAL STRUCTURE; CRYSTALLIZATION; ENZYME ACTIVITY; ENZYME REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; VIBRIO CHOLERAE;

AMINO ACID SEQUENCE; BINDING SITES; CRYSTALLOGRAPHY, X-RAY; LYSOSTAPHIN; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT; VIBRIO CHOLERAE;

VIBRIO CHOLERAE;

EID: 47349088125     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.22095     Document Type: Article

References (34)

1. Hoffmann JA. The immune response of Drosophila. Nature 2003;426:33-38.
2. Medzhitov R, Janeway CA, Jr. Decoding the patterns of self and nonself by the innate immune system. Science 2002;296:298-300.
3. Doyle RJ, Dziarski R. The bacterial cell: peptidoglycan. In: Sussman M, editor. Molecular medical microbiology, Vol. 1, Chapter 7, 2001; p 137-153.
4. van Heijenoort J. Formation of the glycan chains in the synthesis of bacterial peptidoglycan. Glycobiology 2001;11:25R-36R.
5. Stewart-Tull DE. Major component of the cell wall in gram positive organisms. Consists of a glycan backbone with alternating b 1-4 linked residues of N-acetyl-D-glucosamine and muramic acid. The immunological activities of bacterial peptidoglycans. Ann Rev Microbiol 1980;34:311.
6. Ramadurai L, Lockwood KJ, Nadakavukaren MJ, Jayaswal RK. Characterization of a chromosomally encoded glycylglycine endopeptidase of Staphylococcus aureus. Microbiology 1999;145 (Part 4):801-808.
7. Sugai M, Fujiwara T, Akiyama T, Ohara M, Komatsuzawa H, Inoue S, Suginaka H. Purification and molecular characterization of glycylglycine endopeptidase produced by Staphylococcus capitis EPK1. J Bacteriol 1997;179:1193-1202.
8. Kokai-Kun JF, Walsh SM, Chanturiya T, Mond JJ. Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat model. Antimicrob Agents Chemother 2003;47:1589-1597.
9. Dajcs JJ, Thibodeaux BA, Girgis DO, Shaffer MD, Delvisco SM, O'Callaghan RJ. Immunity to lysostaphin and its therapeutic value for ocular MRSA infections in the rabbit. Invest Ophthalmol Vis Sci 2002;43:3712-3716.
10. Dajcs JJ, Thibodeaux BA, Hume EB, Zheng X, Sloop GD, O'Callaghan RJ. Lysostaphin is effective in treating methicillin-resistant Staphylococcus aureus endophthalmitis in the rabbit. Curr Eye Res 2001;22:451-457.
11. Bochtler M, Odintsov SG, Marcyjaniak M, Sabala I. Similar active sites in lysostaphins and D-Ala-D-Ala metallopeptidases. Protein Sci 2004;13:854-861.
12. Firczuk M, Mucha A, Bochtler M. Crystal structures of active LytM. J Mol Biol 2005;354:578-590.
13. Odintsov SG, Sabala I, Marcyjaniak M, Bochtler M. Latent LytM at 1.3A resolution. J Mol Biol 2004;335:775-785.
14. Mooi FR, Bik EM. The evolution of epidemic Vibrio cholerae strains. Trends Microbiol 1997;5:161-165.
15. Finne J, Breimer ME, Hansson GC, Karlsson KA, Leffler H, Vliegenthart JF, van Halbeek H. Novel polyfucosylated N-linked glycopeptides with blood group A. H, X, and Y determinants from human small intestinal epithelial cells J Biol Chem 1989;264:5720-5735.
16. Otwinowski ZM, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 1997;276:307-326.
17. Uson I, Sheldrick GM. Advances in direct methods for protein crystallography. Curr Opin Struct Biol 1999;9:643-648.
18. Fortelle EDL, Bricogne G. Maximum-likelihood heavy atom parameter refinement in the MIR and MAD methods. Methods Enzymol 1997;276:472-493.
19. CCP4. Programs for protein crystallography. Acta Crystallogr D 1994;50:760-763.
20. Jones TA, Zou JY, Cowan SW, Kjeldgaard M. Improved methods for the building of protein models in electron density maps and the location of errors in these models. Acta Crystallogr A 1991;A47:110-119.
21. Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, Read RJ, Rice LM, Simonson T, Warren GL. Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 1998;54 (Part 5):905-921.
22. Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PRO-CHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 1993;26:283-291.
23. Holm L, Sander C. Dali: a network tool for protein structure comparison. Trends Biochem Sci 1995;20:478-480.
24. Takeda K, Miyatake H, Yokota N, Matsuyama S, Tokuda H, Miki K. Crystal structures of bacterial lipoprotein localization factors Lol A and Lol B. EMBO J 2003;22:3199-3209.
25. Weiser JN, Chong ST, Greenberg D, Fong W. Identification and characterization of a cell envelope protein of Haemophilus influenzae contributing to phase variation in colony opacity and nasopharyngeal colonization. Mol Microbiol 1995;17:555-564.
26. Bateman A, Bycroft M. The structure of a LysM domain from E. coli membrane-bound lytic murein transglycosylase D (MltD). J Mol Biol 2000;299:1113-1119.
27. Bielnicki J, Devedjiev Y, Derewenda U, Dauter Z, Joachimiak A, Derewenda ZS. B. subtilis ykuD protein at 2.0-Å resolution: insights into the structure and function of a novel, ubiquitous family of bacterial enzymes. Proteins 2006;62:144-151.
28. 2+-containing D-alanyl-D-alanine-cleaving carboxypeptidase at 2.5-Å resolution. Nature 1982;299:469-470.
29. Hall TM, Porter JA, Beachy PA, Leahy DJ. A potential catalytic site revealed by the 1.7-Å crystal structure of the amino-terminal signalling domain of Sonic hedgehog. Nature 1995;378:212-216.
30. Bussiere DE, Pratt SD, Katz L, Severin JM, Holzman T, Park CH. The structure of VanX reveals a novel amino-dipeptidase involved in mediating transposon-based vancomycin resistance. Mol Cell 1998;2:75-84.
31. Lessard IA, Walsh CT. VanX, a bacterial D-alanyl-D- alanine dipeptidase: resistance, immunity, or survival function? Proc Natl Acad Sci USA 1999;96:11028-11032.
32. Prasadarao NV, Lysenko E, Wass CA, Kim KS, Weiser JN. Opacity-associated protein A contributes to the binding of Haemophilus influenzae to change epithelial cells. Infect Immun 1999;67:4153-4160.
33. Nielsen H, Engelbrecht J, Brunak S, von Heijne G. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng 1997;10:1-6.
34. Nielsen H, Engelbrecht J, Brunak S, von Heijne G. A neural network method for identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Int J Neural Syst 1997;8:581-599.